Here, we use a combination of approaches to evaluate the effects of three TAAR1 agonists on metabolic parameters in rodent models of diabetes, obesity, and iatrogenic weight gain. This evidence concerns the gene TAAR1 and obesity due to melanocortin 4 receptor deficiency.